{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih6ksmadi4r2bcguq4kjukvpbdfzito7jq4vgxaumeer62kbcld2m",
    "uri": "at://did:plc:kpkcscbf2zshv7shqgqn45wn/app.bsky.feed.post/3meh2p2aky7b2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicewazcdp7dvfn364654qdn4jahymcbfcfufv4aeojuzeu7z2hxyi"
    },
    "mimeType": "image/jpeg",
    "size": 1629
  },
  "path": "/story/383389/novo-nordisk-is-taking-hims-hers-to-court.html",
  "publishedAt": "2026-02-09T11:03:00.000Z",
  "site": "https://www.newser.com",
  "textContent": "Novo Nordisk has taken its fight over weight-loss drugs to federal court, targeting telehealth company Hims & Hers over what it calls unauthorized copycats of Wegovy and Ozempic. In a lawsuit filed Monday, the Danish drugmaker asked a court to block Hims & Hers from selling compounded versions of its...",
  "title": "'Complete Sham:' Novo Nordisk Sues Hims & Hers"
}